Plant-Produced Recombinant Influenza A Virus Candidate Vaccine Based on Flagellin Linked to Conservative Fragments of M2 Protein and Hemagglutintin

• Main Authors: Elena A. Blokhina, Eugenia S. Mardanova, Liudmila A. Stepanova, Liudmila M. Tsybalova, Nikolai V. Ravin
• Format: Article
• Language: English
• Published: MDPI AG 2020-01-01
• Series: Plants
• Subjects: influenza; plant; vaccine; flagellin; m2e peptide; hemagglutinin
• Online Access: https://www.mdpi.com/2223-7747/9/2/162

The development of recombinant influenza vaccines with broad spectrum protection is an important task. The combination of conservative viral antigens, such as M2e, the extracellular domain of the transmembrane protein M2, and conserved regions of the second subunit of hemagglutinin (HA), provides an opportunity for the development of universal influenza vaccines. Immunogenicity of the antigens could be enhanced by fusion to bacterial flagellin, the ligand for Toll-like receptor 5, acting as a powerful mucosal adjuvant. In this study, we report the transient expression in plants of a recombinant protein comprising flagellin of <i>Salmonella typhimurium</i> fused to the conserved region of the second subunit of HA (76&#8722;130 a.a.) of the first phylogenetic group of influenza A viruses and four tandem copies of the M2e peptide. The hybrid protein was expressed in <i>Nicotiana benthamiana</i> plants using the self-replicating potato virus X-based vector pEff up to 300 &#181;g/g of fresh leaf tissue. The intranasal immunization of mice with purified fusion protein induced high levels of M2e-specific serum antibodies and provided protection against lethal challenge with influenza A virus strain A/Aichi/2/68(H3N2). Our results show that M2e and hemagglutinin-derived peptide can be used as important targets for the development of a plant-produced vaccine against influenza.